ImmunoGen Inc., a Waltham biotechnology company, has appointed Dr. Charles Morris executive vice president and chief development officer, responsible for leading all aspects of product development. He reports to Daniel Junius, president and chief executive, the company said Monday. Morris had been executive vice president and chief medical officer at Allos Therapeutics Inc. ImmunoGen has three anti-cancer compounds in clinical testing.
ImmunoGen Inc. hires an executive
You've reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week